Athira Pharma, Inc. vs NEUROCRINE BIOSCIENCES INC, risk disclosures compared

6topics both disclose

0only Athira Pharma, Inc.

8only NEUROCRINE BIOSCIENCES INC

What both disclose

Topics appearing in filings from both companies, and how many filings each.

Topic	Athira Pharma, Inc.	NEUROCRINE BIOSCIENCES INC
Cross Border Data Transfer	22	14
Ransomware	10	18
Restatement	5	3
Enforcement Action	3	1
Internal Control	3	1
Data Breach	2	1

Only Athira Pharma, Inc.

Nothing.

Only NEUROCRINE BIOSCIENCES INC

Topic	Filings
Business Continuity	3
Vendor Risk Management	3
AI Governance	1
Artificial Intelligence	1
Identity And Access Management	1
Records Retention	1
Regulatory Reporting	1
Third Party Risk Management	1

What this compares

Which of the topics we track appear in each company's SEC filings, and how often. A topic appearing for one company and not the other means one wrote the phrase down and the other did not, in the filings we hold. It does not mean one faces a risk the other does not, and it is not a comparison of how well either manages anything.

Counts reflect the filings we have collected, which is a growing subset rather than a company's complete history.

Athira Pharma, Inc. · NEUROCRINE BIOSCIENCES INC · All companies